肥胖成人抗菌药物剂量综合指南:2022年更新
本文为2017年肥胖成人抗菌药物剂量指南的更新版叙述性综述,检索PubMed、Web of Science和Cochrane Library后评阅393篇文章,为41种抗菌药物更新剂量推荐。肥胖人群药代动力学变化常被报告但可变且有时矛盾,延长输注、高剂量和治疗药物监测仍是优化剂量的重要策略。
要点
- 肥胖成人药代动力学变化常见但可变,不一定对应临床结局差异。
- 延长输注、高剂量和治疗药物监测是优化肥胖患者剂量的重要策略。
- 需更多研究临床验证剂量策略并明确最佳体型描述指标和肾功能估算方法。
核心结论
- 肥胖成人抗菌药物剂量推荐基于药代动力学研究更新,但缺乏高质量证据且药代动力学变化不总反映临床结局差异。
研究设计与样本
- 叙述性综述,检索PubMed、Web of Science和Cochrane Library,评阅393篇文章,更新41种抗菌药物的剂量推荐。
主要发现
- 多数纳入文章为药代动力学研究,较少为临床研究(多为小型回顾性)、病例报告,指南极少。
- 肥胖人群药代动力学变化常被报告,可变且有时矛盾,不总是转化为临床结局差异。
关键数值与推荐
- 延长输注、高剂量和治疗药物监测是优化肥胖患者剂量的重要策略。
临床怎么用
- 临床可考虑延长输注、高剂量和治疗药物监测优化肥胖成人抗菌药物剂量。
局限性
- 缺乏高质量证据,药代动力学变化不总反映临床结局差异,需更多研究验证剂量策略。
- 需澄清最佳体型描述指标、剂量体重标量和肥胖患者肾功能估算方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug dosing in obese patients continues to be challenging due to a lack of high-quality evidence to guide dosing recommendations. We first published guidance for antibiotic dosing in obese adults in 2017, in which we critically reviewed articles identified from a broad search strategy to develop dosing recommendations for 35 antimicrobials. In this updated narrative review, we searched Pubmed, Web of Science, and the Cochrane Library using Medical Subject Headings including anti-infectives, specific generic antimicrobial names, obese, pharmacokinetics, and others. We reviewed 393 articles, cross-referenced select cited references, and when applicable, referenced drug databases, package inserts, and clinical trial data to update dosing recommendations for 41 antimicrobials. Most included articles were pharmacokinetic studies, other less frequently included articles were clinical studies (mostly small, retrospective), case reports, and very rarely, guidelines. Pharmacokinetic changes are frequently reported, can be variable, and sometimes conflicting in this population, and do not always translate to a documented difference in clinical outcomes, yet are used to inform dosing strategies. Extended infusions, high doses, and therapeutic drug monitoring remain important strategies to optimize dosing in this population. Additional studies are needed to clinically validate proposed dosing strategies, clarify optimal body size descriptors, dosing weight scalars, and estimation method of renal function in obese patients.
引用
- Meng L, Mui E, Ha DR, et al. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Pharmacotherapy. 2023. PMID: 36703246. doi:10.1002/phar.2769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。